Anzeige
Mehr »
Montag, 22.06.2026 - Börsentäglich über 12.000 News
SEAS meldet US-Behörden-Compliance und plant neues Kobalt-Projekt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41JQU | ISIN: CA88024B1022 | Ticker-Symbol: 9DY
Tradegate
22.06.26 | 15:30
0,358 Euro
-4,79 % -0,018
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
TEMPRAMED TECHNOLOGIES LTD Chart 1 Jahr
5-Tage-Chart
TEMPRAMED TECHNOLOGIES LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,3610,39315:30

Aktuelle News zur TEMPRAMED TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04.06.Tempramed Technologies Ltd: Tempramed enters distribution partnership in Brazil9
04.06.TempraMed Technologies Ltd.: TempraMed Signs Agreement for Exclusive Distribution Partnership in Brazil, One of the Largest Diabetes and Biologics Markets Globally1.159HighlightsTempraMed signs Agreement for exclusive distribution in Brazil with Mobil Saúde Comercial Ltda Brazil represents one of the world's largest markets for diabetes, GLP-1 therapies, and temperature-sensitive...
► Artikel lesen
TEMPRAMED TECHNOLOGIES Aktie jetzt für 0€ handeln
22.05.TempraMed Technologies Ltd.: TempraMed Featured on Dr. Phil Show in National US Broadcast Highlighting the Risk of Temperature Exposure for Insulin and Other Medications515Vancouver, British Columbia--(Newsfile Corp. - May 22, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how...
► Artikel lesen
14.05.Tempramed Technologies Ltd: Tempramed receives Indian patent for Vivi Cap Smart8
14.05.TempraMed meldet die Erteilung eines indischen Designpatents für sein VIVI Cap Smart-Produkt410Ein weiterer wichtiger Meilenstein in der kontinuierlichen globalen IP-Strategie, der den Schutz von VIVI Cap Smart auf internationalen Märkten erweitert Highlights ...
► Artikel lesen
14.05.Top News zum Feiertag: Patent bringt Sicherheit!
14.05.TempraMed Technologies Ltd.: TempraMed Announces Granted Indian Design Patent for VIVI Cap Smart Product419HighlightsGranted Patent covers the design of VIVI Cap Smart across major international, growing marketStrengthens the Company's intellectual property position in one of the world's largest healthcare...
► Artikel lesen
30.04.Tempramed Technologies Ltd: Tempramed continues into Ontario11
29.04.TempraMed Technologies Ltd.: TempraMed Announces Continuance into Ontario504Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how...
► Artikel lesen
07.04.Tempramed Technologies Ltd: Tempramed receives Brazilian patent for Vivi Box21
07.04.TempraMed Technologies Ltd.: TempraMed Announces Additional Granted Brazilian Patent for Newest VIVI Box Product283HighlightsBrazilian patent officially granted by the Brazilian Patent Office Covers core innovations underpinning TempraMed's VIVI Box multi-medication storage platform expected to market end of...
► Artikel lesen
30.03.Tempramed Technologies Ltd: Tempramed signs LOI for Panama distribution expansion4
30.03.TempraMed Technologies Ltd.: TempraMed Signs LOI for Distribution Agreement in Panama, Expanding Central American Exposure431Vancouver, British Columbia--(Newsfile Corp. - March 30, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how...
► Artikel lesen
24.03.Tempramed Technologies Ltd: Tempramed receives Chinese patent for Vivi Box6
24.03.TempraMed Technologies Ltd.: TempraMed Strengthens Global Intellectual Property Position with Granted Chinese Patent for Newest Product, VIVI Box400HighlightsChinese patent officially granted by CNIPA on March 17, 2026Covers core innovations underpinning TempraMed's VIVI Box multi-medication storage platform expected to market end of 2026Strengthens...
► Artikel lesen
11.03.Tempramed Technologies Ltd: Tempramed's Vivi Cap evaluated for summer travel use12
11.03.TempraMed Technologies Ltd.: TempraMed's Independently Validated Payer ROI Model for Reimbursement Further Reinforced by a Scientific Publication Highlighting Clinical and Economic Rationale for VIVI Cap638Vancouver, British Columbia--(Newsfile Corp. - March 11, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how...
► Artikel lesen
26.02.Tempramed Technologies Ltd: Tempramed expands U.S. clinician backing3
26.02.TempraMed Technologies Ltd.: TempraMed Reports over 275 Clinicians Recommending VIVI Cap to Patients on Leading FrontrowMD Platform Across the United States325Vancouver, British Columbia--(Newsfile Corp. - February 26, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming...
► Artikel lesen
10.02.Tempramed Technologies Ltd: Tempramed launches products in Israel's Super-Pharm14
Weiter >>
68 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
2,1,9